ERBB2 and lung cancer: A recent study of young patients with nonsmall cell lung cancer showed that higher frequency of ALK and HER2 genetic alterations were associated with young age, while, mutations in KRAS, STK11, and EGFR exon 20 are more common in older patients (Hou et al., 2018).